Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network

Background We validated a case definition for multiple sclerosis using a clinical cohort linked with the Manitoba Primary Care Research Network of the Canadian Primary Care Sentinel Surveillance Network, and applied this definition to describe multiple sclerosis epidemiology using the Canadian Primary Care Sentinel Surveillance Network repository. Methods We developed candidate case definitions for multiple sclerosis in the Manitoba Primary Care Research Network using diagnoses and medications. We compared these case definitions to multiple sclerosis diagnoses identified by applying a validated definition to population-based administrative data (reference standard 1) and multiple sclerosis diagnoses recorded by the provincial Multiple Sclerosis Clinic (reference standard 2) using sensitivity, specificity, positive predictive value and negative predictive value. We applied the preferred case definition to the national Canadian Primary Care Sentinel Surveillance Network dataset. Results The Manitoba Primary Care Research Network included 160,904 patients. The preferred case definition required ≥2 billing records for multiple sclerosis within 2 years or multiple sclerosis listed as a health condition or ≥1 multiple sclerosis-specific prescription. This definition had a low sensitivity versus administrative (44.25%) and clinic datasets (53.41%) but high specificity versus administrative data (99.95%). Specificity was lower versus clinic data (71.43%), but the positive predictive value was high. Conclusion We developed a case definition for multiple sclerosis that can be applied to the Canadian Primary Care Sentinel Surveillance Network dataset for studies examining primary care of persons with multiple sclerosis.

[1]  Christopher L. Fillmore,et al.  Identifying Patients With Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Healthcare Data. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  R. Reid,et al.  Population-based use of mental health services and patterns of delivery among family physicians, 1992 to 2001. , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[3]  Jeffrey A. Cohen,et al.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.

[4]  T. Williamson,et al.  From patient care to research: a validation study examining the factors contributing to data quality in a primary care electronic medical record database , 2015, BMC Family Practice.

[5]  Tyler Williamson,et al.  Data Resource Profile: National electronic medical record data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). , 2017, International journal of epidemiology.

[6]  R. Marrie,et al.  Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis , 2011, Multiple sclerosis.

[7]  R. Marrie,et al.  Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis , 2010, Neurology.

[8]  Suzy L. Wong,et al.  Multiple sclerosis: Prevalence and impact. , 2018, Health reports.

[9]  R. Marrie,et al.  Comorbidity increases the risk of hospitalizations in multiple sclerosis , 2015, Neurology.

[10]  M. Jhaveri,et al.  All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States , 2010, Journal of managed care pharmacy : JMCP.

[11]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[12]  Tyler Williamson,et al.  Validating the 8 CPCSSN Case Definitions for Chronic Disease Surveillance in a Primary Care Database of Electronic Health Records , 2014, The Annals of Family Medicine.

[13]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[14]  Nancy Xiaonan Yu,et al.  High rates of physician services utilization at least five years before multiple sclerosis diagnosis , 2013, Multiple sclerosis.

[15]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[16]  N. Ivers,et al.  Identifying individuals with multiple sclerosis in an electronic medical record , 2015, Multiple sclerosis.

[17]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[18]  R. Marrie,et al.  Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan , 2018, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  Nancy Xiaonan Yu,et al.  Effect of comorbidity on mortality in multiple sclerosis , 2015, Neurology.

[20]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[21]  C. A. Jones,et al.  Health Status and Health Care Utilization of Multiple Sclerosis in Canada , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[22]  Marshall Godwin,et al.  Identification of Dyslipidemic Patients Attending Primary Care Clinics Using Electronic Medical Record (EMR) Data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) Database , 2017, Journal of Medical Systems.

[23]  J. Sim,et al.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements. , 2005, Physical therapy.